Abbott Receives Approval For Xience Prime Everolimus Eluting Stent In Japan NASDAQ (RTTNews.com) - Abbott (ABT) on Monday said it has received approval from the Japanese Ministry of Health, Labor and Welfare for the next-generation Xience Prime Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent ... |
